EVENTS


6th NASH Roundtable™ Forum – Clinical Trials with Non-Invasive Tests (NITs) Instead of Histology: Fact or Fancy?

More information »

5th NASH Roundtable™ Virtual Forum – Is Digital Pathology a Game-Changer for Histology for NASH Drug Development?

More information »

RESOURCES


Fact Sheet: NASH Roundtable™, leading clinical development experts addressing challenges in NASH drug development

View Fact Sheet »

MEMBER CO-AUTHORED PUBLICATIONS


December 2022

A Class Effect Network Meta-analysis of Lipid Modulation in Non-alcoholic Steatohepatitis for Dyslipidemia Read More »

November 2022

Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD) Read More »

November 2022

MAFLD vs. NAFLD not an emotional political process – rather Evidence-Based Medicine Read More »

November 2022

A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes Read More »